Contineum Therapeutics (CTNM) Stock: Buy, Sell, or Hold?
CTNM - Contineum Therapeutics, Inc. Class A Common Stock
$12.99
-0.43 (-3.20%)
▼
5d:
+4.0%
30d:
-21.51%
90d:
-13.97%
HOLD
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Oct 29, 2026
26d
Get Alerted When CTNM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CTNM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CTNM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CTNM is currently trading at $12.99, which is considered slightly low relative to its 30-day fair value range of $13.03 to $16.69.
Technical Outlook: Technically, CTNM is in a strong uptrend. Immediate support is located at $10.84, while resistance sits at $14.00. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: CTNM scores 91/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $22.14 (+70.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CTNM is in a strong uptrend. Immediate support is located at $10.84, while resistance sits at $14.00. Short-term momentum is weak, with the stock down 3.2% recently.
Market Sentiment: CTNM scores 91/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $22.14 (+70.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$13.03 -
$16.69
Company Quality Score
71/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (91/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.2%)
- BULLISH: Trading 70.5% below Wall St target ($22.14)
- CAUTION: Bottoming setup, but lagging the sector by 37% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$13.03 -
$16.69
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$10.84
Resistance Level
$14.00
Current Trend
Strong Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.78
Wall Street Target
$22.14
(+70.5%)
Share & Embed Analysis
Last updated: October 02, 2026 3:32 AM ET
Data refreshes hourly during market hours. Next update: 4:32 AM
Data refreshes hourly during market hours. Next update: 4:32 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CTNM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$92 | 59 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$109 | 73 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$34 | 61 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 44 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 62 BUY |
